RxDoctor Payments DataLook up a doctor →

William Seger, MD

Family Medicine · Fort Worth, TXNPI 1417927971

Payments from drug & device makers

$27,462,750in general payments, 2019–2025

Across 5,542 payments — averaging $4955.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$16.3M
  • Pfizer$7.4M
  • Emergent Biosolutions Inc.$1.1M
  • Merck$840K
  • Seqirus USA Inc$686K
  • Novavax Inc$629K
  • plus $534K from 38 others
$3,200in research payments, 2019–2025

Across 1 payment — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.2,932$16,319,625
Pfizer433$7,366,164
Emergent Biosolutions Inc.1,099$1,087,744
Merck48$839,687
Seqirus USA Inc388$686,291
Novavax Inc58$629,337
GSK236$510,662
AstraZeneca21$9,480
Eisai Inc.4$8,701
Boehringer Ingelheim49$758
AbbVie(2 entities)46$608
Novo Nordisk35$402
Astellas Pharma US Inc21$361
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$342
Sanofi-aventis U.S. LLC9$288
Lilly USA, LLC15$240
Dexcom, Inc.14$227
Bayer8$221
Abbott11$212
Johnson & Johnson(2 entities)10$178
Exact Sciences8$125
Sunovion Pharmaceuticals Inc.18$125
Mylan Specialty L.p.5$111
Novartis6$98
Genentech USA, Inc.7$93
Amgen6$92
Inspire Medical Systems, Inc.2$76
Takeda Pharmaceuticals U.S.A., Inc.4$56
Otsuka America Pharmaceutical, Inc.3$53
Xeris Pharmaceuticals, Inc.3$49
Kowa Pharmaceuticals America, Inc.3$45
Amarin Pharma, Inc.2$36
Biohaven Pharmaceutical Holding Company Ltd.2$35
Sanofi Pasteur Inc.2$35
E.r. Squibb & Sons, L.L.C.2$33
Scilex Pharmaceuticals Inc.2$26
Si-bone, Inc.1$24
Mirum Pharmaceuticals, Inc.1$21
Cranial Technologies, Inc1$17
Shield Therapeutics Inc1$16
IBSA Pharma Inc.1$16
Cipher Pharmaceuticals US LLC1$16
Assertio Therapeutics, Inc.1$13
Ironshore Pharmaceuticals Inc.1$12

How this compares

$27,462,750 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas →

Medicare billing

Part B allowed, 2024
$76,353
Medicare patients
292
Services billed
1,856

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Fort Worth

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →